Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...

† Primum (2 patients), secundum (68 patients) and sinus defects (4 patients). § Surgical branch of the study. TEE = Transesophageal echocardiography. *Children and adults. † Percutaneous branch of the ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.

Abbott Laboratories continues to push its presence in the cardiovascular market with offerings for the left atrial appendage (LAA) closure and transcatheter aortic valve implant (TAVI) markets, both ...

Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) occluder for reducing the long-term need for blood-thinning medication in ...